Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

The impact of levetiracetam on challenging behavior.

Hurtado B, Koepp MJ, Sander JW, Thompson PJ.

Epilepsy Behav. 2006 May;8(3):588-92. Epub 2006 Feb 13.

PMID:
16473557
2.

Levetiracetam for people with mental retardation and refractory epilepsy.

Kelly K, Stephen LJ, Brodie MJ.

Epilepsy Behav. 2004 Dec;5(6):878-83.

PMID:
15582836
3.

Positive and negative psychotropic effects of levetiracetam.

Helmstaedter C, Fritz NE, Kockelmann E, Kosanetzky N, Elger CE.

Epilepsy Behav. 2008 Oct;13(3):535-41. doi: 10.1016/j.yebeh.2008.05.012. Epub 2008 Jun 25.

PMID:
18583196
4.

Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 mild to severe cases.

Dinkelacker V, Dietl T, Widman G, Lengler U, Elger CE.

Epilepsy Behav. 2003 Oct;4(5):537-47.

PMID:
14527496
5.

The risk of paradoxical levetiracetam effect is increased in mentally retarded patients.

Szucs A, Clemens Z, Jakus R, Rásonyi G, Fabó D, Holló A, Barcs G, Kelemen A, Janszky J.

Epilepsia. 2008 Jul;49(7):1174-9. doi: 10.1111/j.1528-1167.2008.01585.x.

6.

Long-term use of Levetiracetam in patients with severe childhood-onset epilepsy.

von Stuelpnagel C, Holthausen H, Kluger G.

Eur J Paediatr Neurol. 2007 Nov;11(6):341-5. Epub 2007 Apr 17.

PMID:
17442601
7.

[Experience with levetiracetam in childhood epilepsy].

Neuwirth M, Saracz J, Hegyi M, Paraicz E, Kollár K, Móser J, Rosdy B, Herczegfalvi A, Fogarasi A.

Ideggyogy Sz. 2006 May 20;59(5-6):179-82. Hungarian.

PMID:
16786712
8.

Levetiracetam in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.

Bootsma HP, Ricker L, Diepman L, Gehring J, Hulsman J, Lambrechts D, Leenen L, Majoie M, Schellekens A, de Krom M, Aldenkamp AP.

Epilepsy Behav. 2007 Mar;10(2):296-303. Epub 2007 Feb 20.

PMID:
17317325
9.

Effect of age and comedication on levetiracetam pharmacokinetics and tolerability.

Hirsch LJ, Arif H, Buchsbaum R, Weintraub D, Lee J, Chang JT, Resor SR Jr, Bazil CW.

Epilepsia. 2007 Jul;48(7):1351-9. Epub 2007 Jun 15.

10.

Long-term continuation of levetiracetam in patients with refractory epilepsy.

Krakow K, Walker M, Otoul C, Sander JW.

Neurology. 2001 Jun 26;56(12):1772-4.

PMID:
11425954
11.

[Follow-up study on levetiracetam monotherapy in children with epilepsy].

Gao ZJ, Jiang YW.

Zhongguo Dang Dai Er Ke Za Zhi. 2008 Dec;10(6):711-4. Chinese.

PMID:
19102836
12.
13.

Suicidal ideation in epilepsy and levetiracetam therapy.

Mula M, Sander JW.

Epilepsy Behav. 2007 Aug;11(1):130-2. Epub 2007 Jun 1.

PMID:
17544331
14.

A prospective analysis of the outcome of levetiracetam in clinical practice.

Nicolson A, Lewis SA, Smith DF.

Neurology. 2004 Aug 10;63(3):568-70.

PMID:
15304598
15.

[Efficacy and safety of levetiracetam (keppra) add-on treatment in adult patients with refractory epilepsy in two tertiary centers].

Auriel E, Chistik V, Blatt I, Margolin N, Neufeld M.

Harefuah. 2007 Apr;146(4):269-71, 318. Hebrew.

PMID:
17476932
16.

Effect of levetiracetam on cognitive functions and quality of life: a one-year follow-up study.

López-Góngora M, Martínez-Domeño A, García C, Escartín A.

Epileptic Disord. 2008 Dec;10(4):297-305. doi: 10.1684/epd.2008.0227.

17.

Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects.

Brodtkorb E, Klees TM, Nakken KO, Lossius R, Johannessen SI.

Epilepsy Behav. 2004 Apr;5(2):231-5.

PMID:
15123025
18.

Role of levetiracetam in the treatment of epilepsy.

Brodie MJ, French JA.

Epileptic Disord. 2003 May;5 Suppl 1:S65-72. Review.

19.

Discontinuation of levetiracetam because of behavioral side effects: a case-control study.

White JR, Walczak TS, Leppik IE, Rarick J, Tran T, Beniak TE, Matchinsky DJ, Gumnit RJ.

Neurology. 2003 Nov 11;61(9):1218-21.

PMID:
14610123
20.

Levetiracetam for the treatment of epilepsy among adults with intellectual disabilities.

Deb S, Kaur Saini ST.

J Intellect Disabil Res. 2007 Jul;51(Pt 7):564-5. No abstract available.

PMID:
17537170

Supplemental Content

Support Center